Parker, J. L., Zhang, Z. Y., & Buckstein, R. (2011). Clinical Trial Risk in Non-Hodgkin’s Lymphoma: Endpoint and Target Selection. Journal of Pharmacy & Pharmaceutical Sciences, 14(2), 227–235. https://doi.org/10.18433/J39P45